| Primary |
| Mycosis Fungoides |
46.4% |
| Acute Myeloid Leukaemia |
6.1% |
| Arrhythmia |
5.1% |
| T-cell Lymphoma |
5.1% |
| Hypothyroidism |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Myelodysplastic Syndrome |
3.1% |
| Dyslipidaemia |
2.6% |
| Lymphoma |
2.6% |
| Thyroid Cancer |
2.6% |
| Headache |
2.0% |
| Hormone Replacement Therapy |
2.0% |
| Lymphomatoid Papulosis |
2.0% |
| Peripheral T-cell Lymphoma Unspecified |
2.0% |
| Reflux Gastritis |
2.0% |
| Supplementation Therapy |
2.0% |
| Bladder Cancer |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Metastasis |
1.5% |
| Pruritus |
1.5% |
|
| Cardiac Failure |
7.7% |
| Pneumonia |
7.7% |
| Dehydration |
6.4% |
| Hypertriglyceridaemia |
6.4% |
| Sepsis |
6.4% |
| Hypothyroidism |
5.1% |
| International Normalised Ratio Increased |
5.1% |
| Leukopenia |
5.1% |
| Malignant Neoplasm Progression |
5.1% |
| Neoplasm Malignant |
5.1% |
| Skin Exfoliation |
5.1% |
| Visual Impairment |
5.1% |
| Acute Coronary Syndrome |
3.8% |
| Diverticulitis |
3.8% |
| Haemoptysis |
3.8% |
| Myoglobin Blood Increased |
3.8% |
| Pulmonary Hypertension |
3.8% |
| Pyrexia |
3.8% |
| Visual Disturbance |
3.8% |
| Aortic Dilatation |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
19.4% |
| Mycosis Fungoides |
17.9% |
| T-cell Lymphoma |
9.5% |
| Hypothyroidism |
8.5% |
| Hypertension |
6.5% |
| Hypercholesterolaemia |
5.0% |
| Arrhythmia |
4.5% |
| Depression |
4.5% |
| Drug Use For Unknown Indication |
3.5% |
| Dyslipidaemia |
3.0% |
| Mycosis Fungoides Stage Iii |
3.0% |
| Premedication |
3.0% |
| Pruritus |
2.5% |
| Blood Cholesterol Increased |
2.0% |
| Vomiting |
2.0% |
| Non-small Cell Lung Cancer |
1.5% |
| Acute Myeloid Leukaemia |
1.0% |
| Anaplastic Large-cell Lymphoma |
1.0% |
| Fibrosis |
1.0% |
| Lymphomatoid Papulosis |
1.0% |
|
| Thrombocytopenia |
16.4% |
| Dehydration |
7.3% |
| Lymphopenia |
7.3% |
| Cerebrovascular Accident |
5.5% |
| Malignant Neoplasm Progression |
5.5% |
| Osteonecrosis |
5.5% |
| Pyrexia |
5.5% |
| Visual Impairment |
5.5% |
| Delirium |
3.6% |
| Haematochezia |
3.6% |
| Hypertriglyceridaemia |
3.6% |
| Hypoglycaemia |
3.6% |
| Hypothyroidism |
3.6% |
| Leukopenia |
3.6% |
| Oedema Peripheral |
3.6% |
| Pancreatic Carcinoma |
3.6% |
| Skin Lesion |
3.6% |
| Subdural Haematoma |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Asthenia |
1.8% |
|
| Concomitant |
| Eczema |
58.2% |
| T-cell Lymphoma |
9.0% |
| Mycosis Fungoides |
7.5% |
| Benign Prostatic Hyperplasia |
4.5% |
| Dysuria |
3.0% |
| Hypertension |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Amnesia |
1.5% |
| Antidepressant Therapy |
1.5% |
| Blood Cholesterol |
1.5% |
| Blood Testosterone Decreased |
1.5% |
| Iron Overload |
1.5% |
| Pain |
1.5% |
| Pruritus |
1.5% |
| Wound Infection |
1.5% |
|
| Weight Decreased |
16.0% |
| Weight Increased |
14.0% |
| T-cell Lymphoma |
8.0% |
| Uterine Leiomyoma |
8.0% |
| White Blood Cell Count Increased |
8.0% |
| Skin Ulcer |
6.0% |
| Sunburn |
6.0% |
| Mycosis Fungoides |
4.0% |
| Urinary Tract Disorder |
4.0% |
| Venom Poisoning |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Acute Myeloid Leukaemia |
2.0% |
| Asthenia |
2.0% |
| Bacterial Disease Carrier |
2.0% |
| Colitis |
2.0% |
| Dysphagia |
2.0% |
| Dyspnoea |
2.0% |
| Haemorrhage |
2.0% |
| Myocardial Ischaemia |
2.0% |
| Petit Mal Epilepsy |
2.0% |
|
| Interacting |
| Hiv Infection |
37.5% |
| Pulmonary Embolism |
37.5% |
| Mycosis Fungoides |
12.5% |
| Product Used For Unknown Indication |
12.5% |
|
| International Normalised Ratio Increased |
75.0% |
| Virologic Failure |
25.0% |
|
